Top 10 most anticipated drug launches of 2023

Navigating Lung Cancer: 5 Essential Facts Families Should Know About Lung Nodules And Staging

Navigating Lung Cancer: 5 Essential Facts Families Should Know About Lung Nodules and StagingAmerican Lung Association

About every two and a half minutes, someone in the U.S. Is diagnosed with lung cancer. The diagnosis process usually starts with a suspected "nodule." The process of "suspected nodule" to treatment (or other next steps) can be confusing to a person impacted and their family. To help empower people who are newly diagnosed with lung cancer with critical knowledge about lung nodules, staging and treatment, the American Lung Association and Olympus partnered to launch a new educational campaign.

Close to 238,000 people in the U.S. Will be diagnosed with lung cancer this year. Fortunately, more Americans are surviving lung cancer thanks in part to early detection, groundbreaking research and new treatments.

"Accurately staging lung cancer (knowing if the cancer has spread and where in the body) is a critical step in determining the most appropriate treatment for a person. While it may seem like a simple step in the diagnostic process, staging lung cancer can be complicated. The results of the staging process directly impact treatment options, so it is important that physicians follow guidelines and work closely with their patients to educate them about the process and what to expect. People with lung cancer and their families should feel empowered to ask questions and advocate for the highest standard of care throughout the entire cancer journey," said Harold Wimmer, President and CEO of the American Lung Association. "This is why is it imperative to educate people on how lung cancer is staged, the questions to ask and what to expect during the process. We also want to remind people that there is hope and treatment options for each stage of lung cancer. This new campaign will provide reliable, easy-to-digest information and resources to families facing lung cancer." 

There are many steps from discovering a lung nodule to diagnosis, staging and treatment. Each piece of information helps doctors narrow down the most appropriate treatment for a person. It is important for people to be able to advocate for themselves to receive accurate, thorough and timely staging, which directly impacts treatment options and prognosis. 

Here are five things that people should know about lung cancer staging:

There are 3 main scenarios in which lung nodules are found: Lung nodules show up on imaging tests like X-rays and CT scans. Sometimes this is through lung cancer screening, which looks for lung cancer in patients at high risk. Other times, a patient has symptoms and physicians are looking for a cause. Sometimes a lung nodule is discovered when a patient is being treated for another condition. 

Sometimes no action is recommended: Not every lung nodule needs to be treated. In some cases, the most appropriate next step is to re-scan the lungs in several months to see if there are changes. 

Staging uses numbers and letters to describe how far the cancer has spread: If the nodule appears cancerous (malignant), physicians gather information to confirm the cancer and understand its type, size, location and spread. Based on this information, the lung cancer is diagnosed and then assigned a stage using numbers and the letters T, N, and M—size of the primary tumor (T), the number and location of regional lymph nodes (N), and the presence or absence of metastasis (M).

In many cases, patients should wait until their care teams have finished gathering all of the information about their lung cancer before starting treatment: Physicians need to know exactly how far the cancer has spread (amongst other important information) to be able to recommend the most appropriate treatment for a patient. People should work closely with their care team to learn what to expect and the risks and benefits associated with each care decision. 

The Lung Association has new resources about staging and lung nodules: Through this campaign, resources are available to provide more information about lung nodules and staging at Lung.Org/lung-nodules. In addition, the American Lung Association's Lung Helpline is staffed with a Lung Cancer Patient Navigator to help answer any questions a person or their family may have. 

Through this new campaign, the Lung Association and Olympus are partnering to empower people with reliable and easy to digest information, resources and suggested questions to ask their doctor. By understanding the different stages of lung cancer and the diagnosis process, people can be more involved in the decision-making process and can better advocate for themselves and their care.

Learn more at Lung.Org/lung-nodules or Lung.Org/staging.

For more information, contact:

Show

A Breath of Fresh Air in Your Inbox

Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!

Thank You!

You will now receive email updates from the American Lung Association.

Make a Donation

Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more.

Make a Donation Become a Lung Health Insider

Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!

Thank you! You will now receive email updates from the American Lung Association.

Back to Top Accessibility

Skip to main content

Select Your Location

Select your location to view local American Lung Association events and news near you.

Zip Code

Or

State

Update Location Change Language

Lung HelpLine

Talk to our lung health experts at the American Lung Association. Our service is free and we are here to help you.

Please ensure Javascript is enabled for purposes of website accessibility

Lung Cancer News

Oct. 11, 2023 — Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study identified the oncoprotein YB-1 as an ...

Sep. 22, 2023 — A novel drug target has been newly identified in the fight against drug resistance in cancer ...

Sep. 21, 2023 — Small cell lung cancer accounts for about 15 percent of all diagnosed lung cancers and is still associated with a high mortality rate. SCLC tumours often develop resistance to chemotherapy and thus ...

Sep. 12, 2023 — An international team of researchers has demonstrated that a combination of inhibitors may suppress tumor growth and prevent relapse in patients with certain cancers, including head and neck squamous ...

Sep. 4, 2023 — Scientists have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to ...

Aug. 31, 2023 — Vitamin C and other antioxidants stimulate the formation of new blood vessels in lung cancer tumors, a new study shows. The discovery corroborates the idea that dietary supplements containing ...

Aug. 30, 2023 — Fresh discoveries about a type of immune cells could give lung cancer patients a more accurate prognosis and better identify who will benefit from immunotherapies. Researchers found that the location ...

Aug. 14, 2023 — Patients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high. Until now, the precise mechanism ...

Aug. 9, 2023 — New findings may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists have identified a biomarker that may help physicians select lung cancer ...

July 12, 2023 — Cancer therapies that target specific genetic abnormalities in tumors have revolutionized treatment possibilities over the past two decades. While quality of life and survival are improved with ...

July 12, 2023 — Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -- cisplatin. Now, researchers have developed the first ...

June 22, 2023 — Small-cell lung cancer is a particularly aggressive type of tumor with a consistently high mortality rate. In recent years, the research of scientists has significantly contributed to a better ...

Mar. 28, 2023 — Researchers develop a 3D cell culture system to test how inhibiting fibroblast activities can help treat lung cancer. To simulate the tumor microenvironment and mimic real tissues, the team ...

Mar. 17, 2023 — A new study has revealed FDA-approved trametinib and entinostat (which is currently in clinical trials) can be given in tandem to produce fewer and smaller tumors in mice with LKB1-mutated non-small ...

Mar. 15, 2023 — A new study represents a first step towards generating highly detailed 3-dimensional maps of lung tumors using genetically engineered mouse ...

Mar. 13, 2023 — Scientists have discovered why breast cancer cells that have spread to the lungs may 'wake up' following years of sleep -- forming incurable secondary tumors. Their research reveals the ...

Feb. 13, 2023 — Researchers show how stimulating dendritic cells through certain pathways produces strong T cell activity against tumors and works in conjunction with immune checkpoint inhibitors to produce even ...

Feb. 1, 2023 — New data from a clinical trial shows improved rates of survival and reduced risk of recurrence in patients taking osimertinib, a targeted therapy for non-small cell lung cancer ...

Jan. 9, 2023 — A new study found that deleting a gene called KMT2D caused normal (basal) lung cells grown in complex cultures called organoids to transform into lung squamous carcinoma (LUSC) ...

Jan. 4, 2023 — A research team has shown that Sarunashi juice and its constituting component isoquercetin help prevent and reduce lung cancer in laboratory ...

Refractory Neuroendocrine Tumor—response To Liposomal Doxorubicin And Capecitabine

Background. A 61-year-old patient with no relevant medical or family history presented with a 2 month history of refractory dry cough that led to the diagnosis of typical carcinoid tumor of the lung metastatic to the mediastinal lymph nodes and liver. She initially received a long-acting somatostatin analog (octreotide) and chemotherapy with cisplatin and etoposide, which was ineffective.

Investigations. Physical examination, laboratory test, chromogranin A test, CT scan, 111In-diethylenetriaminepentaacetic acid (DTPA)-octreotide scan, 18F-FDG-PET scan, fine-needle and tissue core liver biopsies.

Diagnosis. Pulmonary spindle-cell carcinoid tumor with metastases to mediastinal lymph nodes and liver.

Management. Systemic treatment with oral capecitabine (1,500 mg/m2 daily from day 1 to day 21) and intravenous liposomal doxorubicin (10 mg/m2 on days 1, 8 and 15), both repeated every 4 weeks, administered concomitantly with long-acting octreotide 30 mg every 3 weeks. The patient achieved a significant and long-lasting response with the combination of capecitabine and liposomal doxorubicin. She reported no severe adverse effects.

---